Radiation Dose in Interventional Cardiology Procedures: Urgent Need for Monitoring Dose and Establishing Diagnostic Reference Levels

In plain language

This review of patient dose monitoring policies notes that Canada lacked a formal policy for recording patient dose in interventional cardiology, and describes how one hospital set dose benchmarks.

At a glance

Type of study: Narrative review
Who was studied: Patients
Where: Canada
Topics: Patient dose Regulation and policy Dosimetry and monitoring
Summary based on: the abstract

What it found

Canada had no formal policy for monitoring and recording patient radiation dose in interventional cardiology.
The article reviews American, European and international policies on patient dose monitoring and follow-up.
It describes how one hospital's cardiac catheterization unit set benchmarks to optimize administered dose.
Fluoroscopy in interventional cardiology may expose patients to radiation causing skin injury and cancer, and dose per procedure is poorly understood.

Limits to keep in mind

Narrative policy review with a single-centre description, based on the abstract only; no quantitative dose data reported. Focus is patient dose, not staff exposure.

Radiation Safety in Chronic Total Occlusion Percutaneous Coronary Intervention (2025, Narrative review)
Radiation Protection in Interventional Radiology (2022, Narrative review)
Radiation-Induced Noncancer Risks in Interventional Cardiology: Optimisation of Procedures and Staff and Patient Dose Reduction (2013, Narrative review)
Reference Levels for Diagnostic and Interventional X-ray Exposures in Germany: Development, Handling, and Perspective (2026, Narrative review)
Two Central Nervous System Tumors in One Catheter Lab: Time to Rethink Radiation Protection (2026, Retrospective cohort study)

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.